Else Nutrition Holdings Inc (BABYF)

[pual]

Thanks a lot.
Personally (some may not agree,) I suggest that
- our CEO is totally commited to the products (great) but she also believe that the way to go is just let the market find us instead of telling consumers directly what we are all about.
- The company is financially in great shape (no debt) but 17 million cash is quite small and we therefore may be diluted some more, in a more or less close horizon ... unless revenues start growing SIGNIFICANTLY.
- I see that FDA approval is as far as 18+ months away. I expected a shorter time before now and then? Tha also reinforce my belief that focussing on generating revenues out of our current offerings is critical.

In the next couple of week Else will have been a public company for 3 full years (became listed on US OTC markets in Dec 2019). Else began sales in the U.S. in September 2020 (more than 2 years ago) then established 'shelves all over the world thereafter. The company however only records sales (annual projection next 4 quarters) of more or less CDN $15 to 20 millions (assuming quaterly growth of sales to be 25%). Current market cap is less than CDN $80 millions and with current pps we may soon get delisted from tsx.

As per the last line of your report, our CEO claims the company to ' being overwhelmed by demand'' ... I hope not, otherwise we have an undefined issue out there.